Drug Type Small molecule drug |
Synonyms ABT 822, ABT-822, BRLP 42 + [2] |
Target |
Mechanism HSF1 activators(heat shock transcription factor 1 activators), Protein biosynthesis stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC14H20ClN3O2 |
InChIKeyNMOVJBAGBXIKCG-UHFFFAOYSA-N |
CAS Registry130493-03-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Phase 3 | - | - | |
Lung Cancer | Phase 3 | - | - | |
Diabetic Neuropathies | Phase 2 | HU | - | - |
Diabetic Neuropathies | Phase 2 | GB | - | - |
Myocardial Ischemia | Preclinical | HU | - | - |